2014
DOI: 10.1016/j.antiviral.2014.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
26
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 41 publications
1
26
0
Order By: Relevance
“…Since the inhibitor did not reduce p38 MAPK phosphorylation, there is a possibility that SB203580 may be acting directly on downstream molecules as well as p38 MAPK. Our study supports the previous studies, as p38 MAPK plays an important role in the induction of pro-inflammatory cytokine TNF-α during DENV infection [ 20 ] and modulation of inflammation and pathology in DENV infected mice by p38 MAPK inhibitor, SB203580 [ 54 ]. However, we open up the path to further investigate the downstream signals towards MAPK pathway, which is very important to better understand the pathogenesis of DENV infection.…”
Section: Discussionsupporting
confidence: 92%
See 2 more Smart Citations
“…Since the inhibitor did not reduce p38 MAPK phosphorylation, there is a possibility that SB203580 may be acting directly on downstream molecules as well as p38 MAPK. Our study supports the previous studies, as p38 MAPK plays an important role in the induction of pro-inflammatory cytokine TNF-α during DENV infection [ 20 ] and modulation of inflammation and pathology in DENV infected mice by p38 MAPK inhibitor, SB203580 [ 54 ]. However, we open up the path to further investigate the downstream signals towards MAPK pathway, which is very important to better understand the pathogenesis of DENV infection.…”
Section: Discussionsupporting
confidence: 92%
“…Recently, SB203580 has been shown to improve the clinical manifestations and systemic inflammation in an animal model of DENV infection. This interesting study shows oral administration of SB203580 in immuno-competent AG129 mice, decreases the circulation of pro-inflammatory cytokines (TNF-α, IL-6 and MMP-9) and reduces the leakage resulting a better survival rate [ 54 ]. But interestingly, there is neither in vitro nor in vivo study which shows the mechanism by which SB203580 treatment modulates apoptosis in DENV infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Since a number of p38MAPK inhibitors are in clinical development for treating diseases such as arthritis and chronic obstructive pulmonary disease (Norman, 2015), our study warrants further evaluation of the effects of these inhibitors in other ZIKV-infected in vitro and in vivo models as well as in human subjects, which may lead to a novel therapy for ZIKV-induced pathological changes. This possibility is supported by two related studies showing that administration of p38MAPK inhibitor limits inflammation, prevents hematocrit rise, lymphopenia and liver injury, and improves survival rate in mice infected by DENV (Fu et al, 2014; Sreekanth et al, 2016), another flavivirus that induces overlapped but distinct cellular responses with ZIKV.…”
Section: Discussionmentioning
confidence: 81%
“…p38 MAP kinases have been experimentally validated to act as therapeutic targets for joint diseases, septic shock (Lee et al, 1999), inflammatory diseases (Kumar et al, 2003;Saklatvala, 2004), and myocardial injury (Gao et al, 2002). Recently, it was demonstrated that inhibition of p38 MAP kinase proved beneficial to reduce disease symptoms in dengue hemorrhagic fever (Fu et al, 2014), so inhibiting phosphorylation at this site might be important for viral activity inhibition in Ebola.…”
Section: Analysis Of Solvent Accessibility and Structural Informationmentioning
confidence: 99%